As of Jun 28
| +0.70 / +11.16%|
The 8 analysts offering 12-month price forecasts for Novavax Inc have a median target of 14.00, with a high estimate of 25.00 and a low estimate of 5.75. The median estimate represents a +100.86% increase from the last price of 6.97.
The current consensus among 8 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.